Early prediction of adult lymphoma‐associated haemophagocytic lymphohistiocytosis using an interpretable machine learning model
British Journal of Haematology · 2026-06 · 208 (6) · 2047-2058
DOI: 10.1111/bjh.70447 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Haematology, online erschienen am 23.03.2026. Verfasst von Mengfan Luan und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Qilu Hospital of Shandong University, Jinan, Shandong, China. Hauptthemen laut MEDLINE: Lymphohistiocytosis, Hemophagocytic, Machine Learning, Lymphoma. Die Arbeit nennt 40 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Distinguished Taishan Scholars Plan, the Young Elite sponsorship Program of Shandong Provincial Medical Association.
Abstract (Originalsprache)
Lymphoma‐associated haemophagocytic lymphohistiocytosis (LA‐HLH) is associated with a high mortality rate, making early diagnosis and appropriate treatment critical for improving patient outcomes. In this study, we enrolled 126 patients diagnosed with LA‐HLH and 254 with non‐LA‐HLH. A machine learning‐based predictive model was developed and validated to enable timely differentiation of LA‐HLH from other HLH subtypes. The model incorporated 11 predictive variables for early LA‐HLH prediction, among which the top five most influential were age, ferritin, monocyte percentage, haemoglobin and platelet count. Among seven machine learning algorithms evaluated, the random forest model demonstrated the best performance, achieving an area under the curve (AUC) of 0.946 on the training set and 0.794 on the validation set. We subsequently evaluated combined models that incorporated disease‐specific indicators such as soluble interleukin‐2 receptor (sCD25) and PET‐CT SUVmax, which resulted in a non‐significant increase in AUC on the validation set. Finally, the optimal model was deployed as a web‐based tool to support early aetiological differentiation. This may facilitate prompt initiation of targeted examination and appropriate treatment for patients with LA‐HLH.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Hematology, Qilu Hospital of Shandong University, Jinan, Shandong, China.
- Shandong Key Laboratory of Hematological Diseases and Immune Microenvironment, Qilu Hospital of Shandong University, Jinan, Shandong, China.
- Gastroenterology ICU, Department of Gastroenterology, Qilu Hospital of Shandong University, Jinan, Shandong, China.
- Shandong Provincial Clinical Research Center for Hematological Diseases, Qilu Hospital of Shandong University, Jinan, Shandong, China.
ORCID-Profile: Chunyan Ji
Förderung
- National Natural Science Foundation of China
- Distinguished Taishan Scholars Plan
- the Young Elite sponsorship Program of Shandong Provincial Medical Association
- Key Technology R&D and S/T Benefiting the People Demonstration Project
Zitieren
APA
Luan, M., Jia, R., Wang, D., Zhang, F., Han, X., Sheng, X., Li, S., Zhou, Q., Li, B., Ning, C., Ji, C., Ye, J., Zang, S., & Lu, F. (2026). Early prediction of adult lymphoma‐associated haemophagocytic lymphohistiocytosis using an interpretable machine learning model. British Journal of Haematology, 208(6), 2047-2058. https://doi.org/10.1111/bjh.70447
Vancouver
Luan M, Jia R, Wang D, Zhang F, Han X, Sheng X, et al. Early prediction of adult lymphoma‐associated haemophagocytic lymphohistiocytosis using an interpretable machine learning model. British Journal of Haematology. 2026;208(6):2047-2058. doi:10.1111/bjh.70447
BibTeX
@article{Luan2026,
author = {Luan, Mengfan and Jia, Ruinan and Wang, DongMei and Zhang, Fan and Han, Xiao and Sheng, Xue and Li, Shuying and Zhou, Qirui and Li, Boya and Ning, Chenchen and Ji, Chunyan and Ye, Jingjing and Zang, Shaolei and Lu, Fei},
title = {Early prediction of adult lymphoma‐associated haemophagocytic lymphohistiocytosis using an interpretable machine learning model},
journal = {British Journal of Haematology},
year = {2026},
volume = {208},
number = {6},
pages = {2047--2058},
doi = {10.1111/bjh.70447}
}
EUVIMED